WINDTREE THERAPEUTICS INC /DE/ (WINT) Share-based Payment Arrangement, Expense USD 2011 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Windtree Therapeutics Inc /De/ quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2011 to 2024.
  • Windtree Therapeutics Inc /De/ Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $251 K, a 11.9% decline year-over-year.
  • Windtree Therapeutics Inc /De/ Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $1.24 M, a 52.2% decline year-over-year.
  • Windtree Therapeutics Inc /De/ annual Share-based Payment Arrangement, Expense for 2023 was $1.28 M, a 58.6% decline from 2022.
  • Windtree Therapeutics Inc /De/ annual Share-based Payment Arrangement, Expense for 2022 was $3.09 M, a 57.4% decline from 2021.
  • Windtree Therapeutics Inc /De/ annual Share-based Payment Arrangement, Expense for 2021 was $7.24 M, a 27.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.24 M $251 K -$34 K -11.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.28 M $306 K -$485 K -61.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 $1.76 M $305 K -$439 K -59% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $2.2 M $382 K -$399 K -51.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $2.6 M $285 K -$485 K -63% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $3.09 M $791 K -$831 K -51.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 $3.92 M $744 K -$885 K -54.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $4.8 M $781 K -$763 K -49.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $5.57 M $770 K -$1.67 M -68.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $7.24 M $1.62 M +$341 K +26.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $6.9 M $1.63 M +$481 K +41.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $6.42 M $1.54 M -$22 K -1.41% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $6.44 M $2.44 M +$754 K +44.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $5.68 M $1.28 M -$232 K -15.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $5.92 M $1.15 M -$791 K -40.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $6.71 M $1.57 M -$173 K -9.95% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $6.88 M $1.69 M +$159 K +10.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $6.72 M $1.51 M +$1.26 M +500% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-29
Q3 2019 $5.46 M $1.94 M +$1.79 M +1237% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $3.67 M $1.74 M +$1.6 M +1142% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $2.07 M $1.53 M +$1.11 M +266% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $955 K $252 K -$577 K -69.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-03
Q3 2018 $1.53 M $145 K -$33 K -18.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $1.57 M $140 K -$114 K -44.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $1.68 M $418 K +$118 K +39.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q4 2017 $1.56 M $829 K +$532 K +179% Oct 1, 2017 Dec 31, 2017 10-K/A 2019-04-23
Q3 2017 $1.03 M $178 K -$95 K -34.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $1.12 M $254 K +$4 K +1.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $1.12 M $300 K -$303 K -50.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 $1.42 M $297 K -$47 K -13.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 $1.47 M $273 K -$145 K -34.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $1.62 M $250 K -$85 K -25.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 $1.7 M $603 K +$4 K +0.67% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $1.7 M $344 K -$256 K -42.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 $1.95 M $418 K -$439 K -51.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $2.39 M $335 K -$446 K -57.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 $2.84 M $599 K -$104 K -14.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 $2.94 M $600 K -$6 K -0.99% Oct 1, 2014 Dec 31, 2014 10-K/A 2016-03-29
Q3 2014 $2.95 M $857 K +$216 K +33.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $2.73 M $781 K +$174 K +28.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $2.56 M $703 K +$347 K +97.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $2.21 M $606 K -$527 K -46.5% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 $2.74 M $641 K +$167 K +35.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $2.57 M $607 K +$201 K +49.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $2.37 M $356 K -$42 K -10.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $2.41 M $1.13 M Oct 1, 2012 Dec 31, 2012 10-K 2015-03-16
Q3 2012 $474 K +$326 K +220% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $406 K +$223 K +122% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $398 K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-07
Q3 2011 $148 K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $183 K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.